Alteration of Fatty Acid Profile in Fragile X Syndrome
Fragile X Syndrome (FXS) is the most prevalent monogenic cause of Autism Spectrum Disorders (ASDs). Despite a common genetic etiology, the affected individuals display heterogenous metabolic abnormalities including hypocholesterolemia. Although changes in the metabolism of fatty acids (FAs) have bee...
Main Authors: | Armita Abolghasemi, Maria Paulina Carullo, Ester Cisneros Aguilera, Asma Laroui, Rosalie Plantefeve, Daniela Rojas, Serine Benachenhou, María Victoria Ramírez, Mélodie Proteau-Lemieux, Jean-François Lepage, François Corbin, Mélanie Plourde, Mauricio Farez, Patricia Cogram, Artuela Çaku |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/18/10815 |
Similar Items
-
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
by: Asma Laroui, et al.
Published: (2022-09-01) -
Association of lipid rafts cholesterol with clinical profile in fragile X syndrome
by: Amanda Toupin, et al.
Published: (2022-02-01) -
Multimodal assessment of the GABA system in patients with fragile-X syndrome and neurofibromatosis of type 1
by: Angelina Lacroix, et al.
Published: (2022-11-01) -
Phenotypic Trade-Offs: Deciphering the Impact of Neurodiversity on Drug Development in Fragile X Syndrome
by: Truong An Bui, et al.
Published: (2021-10-01) -
Fragile X syndrome - insight into what we know and prospects
by: Adam Strzoda, et al.
Published: (2023-04-01)